MCE - Delayed Quote EUR
Vytrus Biotech, S.A. (VYT.MC)
3.2000
0.0000
(0.00%)
At close: April 25 at 4:00:23 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
904.3906
904.3906
1,026.0333
447.9215
Investing Cash Flow
-1,181.2600
-1,181.2600
-1,326.4396
-302.7747
Financing Cash Flow
656.9859
656.9859
-258.2266
45.0232
End Cash Position
1,104.7370
1,104.7370
724.6205
1,283.2535
Capital Expenditure
-1,166.2241
-1,166.2241
-1,294.6521
-271.8155
Issuance of Capital Stock
115.4629
115.4629
171.9217
250.3701
Issuance of Debt
1,645.9077
1,645.9077
381.4971
265.5238
Repayment of Debt
-683.2753
-683.2753
-347.0595
-271.5055
Repurchase of Capital Stock
-421.1093
-421.1093
-464.5860
-199.3652
Free Cash Flow
-261.8336
-261.8336
-268.6188
176.1060
12/31/2021 - 3/15/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22Z.SG Zealand Pharma A/S
56.48
+2.92%
HTD.MU Corcept Therapeutics Inc
62.76
+4.25%
HQ1.MU Oruka Therapeutics Inc. R
9.15
0.00%
0M4.DU Mersana Therapeutics Inc
0.3123
-7.25%
GNRO.PA GeNeuro SA
0.0712
+1.71%
GON.DU Geron Corp
1.2275
+0.08%
NXOA.BE Nicox SA
0.2340
+3.54%
OCD1.MU ChromaDex Corp
6.40
+3.23%
APE1.SG Addex Therapeutics Ltd
6.85
+7.03%
IXI.L IXICO plc
9.00
0.00%